BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

184 related articles for article (PubMed ID: 15114658)

  • 1. Myelin oligodendrocyte glycoprotein-35-55 peptide induces severe chronic experimental autoimmune encephalomyelitis in HLA-DR2-transgenic mice.
    Rich C; Link JM; Zamora A; Jacobsen H; Meza-Romero R; Offner H; Jones R; Burrows GG; Fugger L; Vandenbark AA
    Eur J Immunol; 2004 May; 34(5):1251-61. PubMed ID: 15114658
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A humanized model for multiple sclerosis using HLA-DR2 and a human T-cell receptor.
    Madsen LS; Andersson EC; Jansson L; krogsgaard M; Andersen CB; Engberg J; Strominger JL; Svejgaard A; Hjorth JP; Holmdahl R; Wucherpfennig KW; Fugger L
    Nat Genet; 1999 Nov; 23(3):343-7. PubMed ID: 10610182
    [TBL] [Abstract][Full Text] [Related]  

  • 3. T-cell hybridoma specific for myelin oligodendrocyte glycoprotein-35-55 peptide produced from HLA-DRB1*1501-transgenic mice.
    Chou YK; Culbertson N; Rich C; LaTocha D; Buenafe AC; Huan J; Link J; Wands JM; Born WK; Offner H; Bourdette DN; Burrows GG; Vandenbark AA
    J Neurosci Res; 2004 Sep; 77(5):670-80. PubMed ID: 15352213
    [TBL] [Abstract][Full Text] [Related]  

  • 4. T cell epitope spreading to myelin oligodendrocyte glycoprotein in HLA-DR4 transgenic mice during experimental autoimmune encephalomyelitis.
    Klehmet J; Shive C; Guardia-Wolff R; Petersen I; Spack EG; Boehm BO; Weissert R; Forsthuber TG
    Clin Immunol; 2004 Apr; 111(1):53-60. PubMed ID: 15093552
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Monomeric DR2/MOG-35-55 recombinant TCR ligand treats relapses of experimental encephalomyelitis in DR2 transgenic mice.
    Link JM; Rich CM; Korat M; Burrows GG; Offner H; Vandenbark AA
    Clin Immunol; 2007 Apr; 123(1):95-104. PubMed ID: 17257899
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Recombinant TCR ligand induces tolerance to myelin oligodendrocyte glycoprotein 35-55 peptide and reverses clinical and histological signs of chronic experimental autoimmune encephalomyelitis in HLA-DR2 transgenic mice.
    Vandenbark AA; Rich C; Mooney J; Zamora A; Wang C; Huan J; Fugger L; Offner H; Jones R; Burrows GG
    J Immunol; 2003 Jul; 171(1):127-33. PubMed ID: 12816990
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Identification of T cell epitopes on human proteolipid protein and induction of experimental autoimmune encephalomyelitis in HLA class II-transgenic mice.
    Mangalam AK; Khare M; Krco C; Rodriguez M; David C
    Eur J Immunol; 2004 Jan; 34(1):280-90. PubMed ID: 14971054
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Limited repertoire of HLA-DRB1*0401-restricted MBP111-129-specific T cells in HLA-DRB1*0401 Tg mice and their pathogenic potential.
    Huh J; Yao K; Quigley L; Ludwin SK; McFarland HF; Muraro PA; Martin R; Ito K
    J Neuroimmunol; 2004 Jun; 151(1-2):94-102. PubMed ID: 15145608
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A novel protective model against experimental allergic encephalomyelitis in mice expressing a transgenic TCR-specific for myelin oligodendrocyte glycoprotein.
    Mendel I; Natarajan K; Ben-Nun A; Shevach EM
    J Neuroimmunol; 2004 Apr; 149(1-2):10-21. PubMed ID: 15020060
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of the bm12 class II mutation on proliferative and cytokine responses of encephalitogenic T cells in myelin oligodendrocyte glycoprotein (MOG)-induced experimental autoimmune encephalomyelitis.
    Gur H; Mendel I; Kerlero de Rosbo N; Ben-Nun A
    J Autoimmun; 1999 Aug; 13(1):3-10. PubMed ID: 10441162
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hla-DR2-restricted responses to proteolipid protein 95-116 peptide cause autoimmune encephalitis in transgenic mice.
    Kawamura K; Yamamura T; Yokoyama K; Chui DH; Fukui Y; Sasazuki T; Inoko H; David CS; Tabira T
    J Clin Invest; 2000 Apr; 105(7):977-84. PubMed ID: 10841661
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Efficient presentation of myelin oligodendrocyte glycoprotein peptides but not protein by astrocytes from HLA-DR2 and HLA-DR4 transgenic mice.
    Kort JJ; Kawamura K; Fugger L; Weissert R; Forsthuber TG
    J Neuroimmunol; 2006 Apr; 173(1-2):23-34. PubMed ID: 16386804
    [TBL] [Abstract][Full Text] [Related]  

  • 13. HLA DR and DQ interaction in myelin oligodendrocyte glycoprotein-induced experimental autoimmune encephalomyelitis in HLA class II transgenic mice.
    Khare M; Mangalam A; Rodriguez M; David CS
    J Neuroimmunol; 2005 Dec; 169(1-2):1-12. PubMed ID: 16194572
    [TBL] [Abstract][Full Text] [Related]  

  • 14. HLA-DRB1*1501 risk association in multiple sclerosis may not be related to presentation of myelin epitopes.
    Finn TP; Jones RE; Rich C; Dahan R; Link J; David CS; Chou YK; Offner H; Vandenbark AA
    J Neurosci Res; 2004 Oct; 78(1):100-14. PubMed ID: 15372502
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Structural basis for the binding of an immunodominant peptide from myelin basic protein in different registers by two HLA-DR2 proteins.
    Li Y; Li H; Martin R; Mariuzza RA
    J Mol Biol; 2000 Nov; 304(2):177-88. PubMed ID: 11080454
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Visualization of myelin basic protein (MBP) T cell epitopes in multiple sclerosis lesions using a monoclonal antibody specific for the human histocompatibility leukocyte antigen (HLA)-DR2-MBP 85-99 complex.
    Krogsgaard M; Wucherpfennig KW; Cannella B; Hansen BE; Svejgaard A; Pyrdol J; Ditzel H; Raine C; Engberg J; Fugger L
    J Exp Med; 2000 Apr; 191(8):1395-412. PubMed ID: 10770805
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Activation and control of pathogenic T cells in OSP/claudin-11-induced EAE in SJL/J mice are dominated by their focused recognition of a single epitopic residue (OSP58M).
    Kaushansky N; Eisenstein M; Oved JH; Ben-Nun A
    Int Immunol; 2008 Nov; 20(11):1439-49. PubMed ID: 18801757
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Copolymer effects on microglia and T cells in the central nervous system of humanized mice.
    Illes Z; Stern JN; Keskin DB; Reddy J; Brosnan CF; Waldner H; Santambrogio L; Kuchroo VK; Strominger JL
    Eur J Immunol; 2005 Dec; 35(12):3683-93. PubMed ID: 16259003
    [TBL] [Abstract][Full Text] [Related]  

  • 19. AlphaB-crystallin-reactive T cells from knockout mice are not encephalitogenic.
    Wang C; Chou YK; Rich CM; Link JM; Afentoulis ME; van Noort JM; Wawrousek EF; Offner H; Vandenbark AA
    J Neuroimmunol; 2006 Jul; 176(1-2):51-62. PubMed ID: 16844233
    [TBL] [Abstract][Full Text] [Related]  

  • 20. T cell epitopes of human myelin oligodendrocyte glycoprotein identified in HLA-DR4 (DRB1*0401) transgenic mice are encephalitogenic and are presented by human B cells.
    Forsthuber TG; Shive CL; Wienhold W; de Graaf K; Spack EG; Sublett R; Melms A; Kort J; Racke MK; Weissert R
    J Immunol; 2001 Dec; 167(12):7119-25. PubMed ID: 11739534
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.